Here are four notes:
1. EndoChoice Holdings has a 12-month low of $6.23 and a 12-month high of $19.69.
2. The company has a 50-day moving average of $8.17 and a 200-day moving average of $12.29.
3. The firm’s market cap is $163.65 million.
4. On average, EndoChoice Holdings has a rating of “buy” and a target price of $23.33.
More articles on GI/endoscopy:
GI physician leader to know: Dr. David Alpers of Washington University at St. Louis
Frozen vs. fresh fecal matter for FMT — Does it make a difference? 4 insights
Midwest Gastroenterology adds Dr. Richard Lozoff — 3 points
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.